VetCentric, a US-based provider of pet medication deliveries, has raised $3m as part of a continued round of series B funding, with Switzerland-based chocolate company Nestlé investing $1m.

VetCentric said Nestlé Venture Capital Fund, the corporate venturing division of the Swiss company run by independent manager Inventages, and venture capital firms Sherbrooke Capital and Asset Management Company supported the $3m investment equally.

Ted Root, executive president of VetCentric, said: "We have delivered over 2.5 million orders on behalf of…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?